Previous Article | Next Article ![]()
Journal of Virology, December 2000, p. 11017-11026, Vol. 74, No. 23
Laboratory of Infectious Diseases, National
Institute of Allergy and Infectious Diseases, Bethesda, Maryland
20892-0720
Received 24 May 2000/Accepted 12 September 2000
The intergenic sequences (IGS) between the first nine genes of
human respiratory syncytial virus (RSV) vary in length from 1 to 56 nucleotides and lack apparent conserved sequence motifs. To investigate
their influence on sequential transcription and viral growth,
recombinant RSV strain A2, from which the SH gene had been deleted to
facilitate manipulation, was further modified to contain an M-G IGS of
16, 30, 44, 58, 65, 72, 86, 100, 120, 140, or 160 nucleotides. All of
the viruses were viable. For viruses with an M-G IGS of 100 nucleotides
or more, plaque size decreased with increasing IGS length. In this same
length range, increasing IGS length was associated with modest
attenuation during single-step, but not multistep, growth in HEp-2
cells. Surprisingly, Northern blot analysis of the accumulation of six
different mRNAs indicated that there was little or no change in
transcription with increasing IGS length. Thus, the RSV polymerase
apparently can readily cross IGS of various lengths, including
unnaturally long ones, with little or no effect on the efficiency of
termination and reinitiation. This finding supports the view that the
IGS do not have much effect on sequential transcription and provides
evidence from infectious virus that IGS length is not an important
regulatory feature. To evaluate replication in vivo, BALB/c mice were
infected intranasally with RSV containing an M-G IGS of 65, 140, or 160 nucleotides. Replication of the latter two viruses was decreased up to
5- and 25-fold in the upper and lower respiratory tracts, respectively, on day 3 following infection. However, the level of replication at both
sites on days 4 and 5 was very similar to that of the virus with an IGS
of 65 nucleotides. Thus, the modest attenuation in vivo associated with
the longer IGS was additive to that conferred by deletion of the SH
gene and might be useful to incrementally increase the level of
attenuation of a live-attenuated vaccine virus.
Human respiratory syncytial
virus (RSV) is a member of genus Pneumovirus of family
Paramyxoviridae. RSV is the most important viral agent of
serious respiratory tract disease in infants and young children
worldwide and is an important cause of respiratory tract disease in the
general population and especially in immunocompromised individuals and
the elderly (reference 8 and the references therein). A vaccine against RSV is not yet available, although significant progress toward this goal has been achieved and several live attenuated vaccine candidates have been developed (38).
The genome of RSV is a single strand of negative-sense RNA of 15,222 nucleotides that encodes 10 mRNAs. Viral RNA replication requires the
polymerase (L), nucleoprotein (N), and phosphoprotein (P) (13,
39). Transcription requires in addition the M2-1 transcription
antitermination factor (7, 16). Two additional proteins
appear to regulate or enhance RNA synthesis, although they are not
required for virus growth: the M2-2 protein appears to down-regulate
transcription and up-regulate replication (2, 16), and the
NS1 protein is required for efficient RNA replication (M. Teng and P. Collins, unpublished data).
The RSV genes are arranged on genomic RNA in the order
3'-NS1-NS2-N-P-M-SH-G-F-M2-L, with the M2-1 and M2-2 proteins being encoded by overlapping open reading frames in the M2 mRNA. Each of RSV
genes is flanked on the upstream and downstream ends with gene-start
(GS) and gene-end (GE) semiconserved sequence motifs, which direct
transcriptional initiation and termination, respectively. The first
nine RSV genes are separated by intergenic sequences (IGS) that
are 1 to 56 nucleotides long, lack consensus elements or strong
secondary structures, and vary significantly in sequence and length
among RSV strains (5, 17). The last two genes, M2 and L,
overlap by 68 nucleotides, and the L gene is accessed by a backsliding
polymerase (10).
Among different members of order Mononegavirales, the
nonsegmented negative-strand RNA viruses, the organization of the IGS exhibits two alternative patterns. A number of viruses have short conserved or semiconserved IGS. For example, the rhabdovirus vesicular stomatitis virus (VSV) has the conserved dinucleotide GA or CA as the
IGS, with the sole exception that the G-L IGS of the New Jersey strain
is 21 nucleotides in length (35). The paramyxoviruses Sendai
virus, human parainfluenza virus type (PIV3), bovine PIV3, measles
virus, and rinderpest virus have the trinucleotide GAA or GGG as the
IGS (reviewed in reference 19). Besides RSV, certain other mononegaviruses have longer, more-variable IGS. For example, the
rhabdovirus rabies virus has IGS of 2 to 29 nucleotides
(34). Members of another genus among the paramyxoviruses,
the rubulaviruses, have IGS lengths as follows: simian virus 5 (SV5), 1 to 22 nucleotides; SV41, 3 to 21 nucleotides not including the
incomplete M-F gene junction; mumps virus, 1 to 7 nucleotides;
Newcastle disease virus, 1 to 47 nucleotides (reviewed in references
19 and 21); and human PIV2, 4 to
45 nucleotides (18). Filoviruses also have long and diverse
IGS: Marburg virus, 2 to 95 nucleotides long (EMBL accession no.
Z29337; GenBank accession no. Z12132); and Ebola virus, 3 to 143 nucleotides (27; GenBank accession no. AF086833).
The role of the IGS in the regulation of RNA synthesis has been
investigated for several mononegaviruses. For VSV, studies with a
minireplicon showed that the IGS was essential for reinitiation at the
downstream gene and that some, but not all, sequence substitutions or
small length changes in the IGS strongly influenced termination at the
upstream gene (1, 30-32). In contrast, substitution of the
various naturally occurring RSV IGS into a dicistronic minigenome, or
deletion of the IGS altogether, had no apparent effect on termination, reinitiation, or the production of a readthrough mRNA (20). In studies with an SV5 minireplicon (25), the first IGS
residue immediately downstream the UUUU tract of M GE signal was
necessary for efficient termination of M gene transcription, although
this effect appeared to be limited to that particular GE signal. The introduction of certain nonnatural sequences into an SV5 IGS also influenced the efficiency of reinitiation at the downstream gene. Other
studies compared the naturally occurring gene junctions of RSV in a
minigenome system (14) or of SV5 in infectious recombinant virus (15). These results showed that the different gene
junctions have different effects on sequential transcription. However,
since entire gene junctions were substituted, effects due to GE, IGS, or GS signals could not be distinguished.
In this study, we manipulated the length of a single IGS in infectious
recombinant RSV, varying it from 16 to 160 nucleotides, the latter
being 40% of the length of the smallest RSV gene. The remainder of the
gene junction and indeed the rest of the entire antigenome were held
constant. The panel of recombinant RSVs was then examined for effects
on sequential transcription, RNA replication, plaque formation and
propagation in vitro, and replication and immunogenicity in the
respiratory tracts of mice.
Construction and structure of recombinant RSVs with a modified
M-G IGS.
To facilitate cDNA manipulations, the IGS mutations were
made in an antigenomic cDNA from which the SH gene had been deleted. Deletion of SH from wild-type recombinant strain A2 (wt rRSV) was
described previously (37). That antigenomic backbone
contained several additional mutations for vaccine development purposes that were not desirable here; we therefore imported this SH deletion into the previously described wt rRSV backbone (6) by
restriction fragment replacement (not shown). As summarized in Fig.
1A and described in
detail previously (37), the deletion involved replacing a
ScaI-PacI restriction fragment, bearing most of
the SH gene, with a small synthetic double-stranded DNA. This restored
the M gene noncoding region in its entirety and recreated the GE signal (Fig. 1A). The reconstruction was designed to introduce a single nucleotide change into the M GE signal (AGTTAATAAAAAA
to AGTTAATTAAAAA, with the
change underlined), which created a PacI site (boldface) and
made the signal identical to the original SH GE signal. Thus, in the SH
deletion virus, the M-G gene junction is identical to the naturally
occurring SH-G junction, consisting of the authentic SH GE signal (now
attached to the M gene) followed the authentic 44-nucleotide SH-G IGS,
followed by the authentic G GS. In this SH deletion virus, this gene
junction will be referred to as M-G.
0022-538X/00/$04.00+0
Respiratory Syncytial Virus Can Tolerate an Intergenic Sequence
of at Least 160 Nucleotides with Little Effect on Transcription or
Replication In Vitro and In Vivo
![]()
ABSTRACT
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
![]()
INTRODUCTION
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
![]()
MATERIALS AND METHODS
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

View larger version (30K):
[in a new window]
FIG. 1.
Structures of artificial IGS inserted between the M and
G genes of recombinant RSVs lacking the SH gene. (A) Deletion of the SH
gene. The ScaI-PacI restriction fragment bearing
most of the SH gene was replaced by a synthetic double-stranded DNA
that restored the downstream noncoding region of the M gene and
restored a GE signal. The sequence below the diagram shows the restored
ScaI and PacI sites (underlined) and GE signal
(overlined), and the dashes in the sequence indicate the boundary
between sequence originally derived from the M (left) and SH (right)
genes. The restored signal contains a single nucleotide substitution
(boxed) that creates a PacI site and makes the GE signal
identical to the naturally occurring SH GE signal. GS and GE signals
are shown as white and gray boxes, respectively, and the number of
nucleotides in the IGS is indicated. (B) Structures of IGS between the
M and G genes of rRSV/M-G-16, -30, -44, -58, -72, -86, and -65. rRSV/M-G-44 contains the parental 44-nucleotide IGS modified by
nucleotide substitution at four positions (lowercase letters) to create
a KpnI site (underlined). To create rRSV/M-G-16 and -30, the
indicated deletions (dashed line) were made in the 44-nucleotide IGS
between the M and G genes. The KpnI site introduced into
this IGS was used to accept addition sequence segments, all of which
were derived from increasing increments of the naturally occurring
52-nucleotide G-F IGS, which is shown. The inserts had an additional
GTAC (underlined) at the downstream end that represents an incomplete
KpnI site. Thus, the introduction of incrementally longer
segments of the G-F IGS resulted in the creation of rRSV/M-G-58, -72, and -86. rRSV/M-G-65, constructed in previous work (4),
contains a 21-nucleotide insertion with an XmaI site
(underlined) and was placed immediately downstream of the M GE signal.
(C) Structures of IGS between the M and G genes of rRSV/M-G-100, -120, -140, and -160. The diagram shows the downstream end of the M gene on
the left, the upstream end of the G gene on the right, and the
intervening M-G IGS. The open reading frames (ORF) and GS and GE
transcription signals are shown as filled rectangles; nontranslated
gene regions and the M-G IGS are shown as thin lines. The set of
synthetic M-G IGS was assembled from sequence segments copied from the
naturally occurring G-F and SH-G IGS. These are identified according to
their original sequence position in the complete 15,223-nucleotide
recombinant wt rRSV antigenome, and the nucleotide length of each
segment is indicated above the lines. The left-hand KpnI
site is indicated as 5 nucleotides because it overlaps with the last
nucleotide of the upstream G-F intergenic region; the second
KpnI site, also indicated as 5 nucleotides, is in
parentheses because the complete site was not regenerated by the design
of the construction.
Recovery and propagation of recombinant RSV. Recombinant RSV was recovered by cotransfection of each antigenomic cDNA with support plasmids encoding the N, P, M2-1, and L proteins into HEp-2 cells infected with vaccinia virus recombinant MVA encoding the bacteriophage T7 RNA polymerase (6). The MVA recombinant was kindly supplied by Linda Wyatt and Bernie Moss. Each recombinant virus was designated according to the length of its M-G IGS, i.e., rRSV/M-G-16, -30, -44, and so forth. The modified viruses were amplified by four to five sequential passages in HEp-2 cells. Opti-MEM (Life Technologies) containing 2% fetal bovine serum (Summit Biotechnologies) was used in all infections. After the last passage, the cells and overlying medium were harvested and centrifuged at 500 × g, the supernatants were taken and adjusted to contain 100 mM MgSO4 and 50 mM HEPES sodium salt, and the viruses were aliquoted and frozen. wt rRSV was used as one of the controls; however, this was for descriptive purposes rather than direct comparison because it contains the SH gene.
Reverse transcription-PCR (RT-PCR) analysis of the modified viral IGS. Total RNA was isolated 48 h postinfection from virus-infected HEp-2 cells, using Trizol reagent (Life Technologies) according manufacturer's recommendations with addition of two phenol-chloroform extractions followed by ethanol precipitation. Reverse transcription was performed using SuperScript II reverse transcriptase (Life Technologies) and the positive-sense oligonucleotide primer 5'-TCATCCCAAGTCATTGTT-3' (nucleotides 4158 to 4175 of wt rRSV antigenome) upstream of the M-G gene junction. An aliquot of the cDNA product was used as the template in PCR using the above-mentioned primer together with the negative-sense primer 5'-TATATAAGCACGATGATATG-3', corresponding to nucleotides 4763 to 4782 of the antigenome, downstream of the M-G gene junction. An initial 2-min denaturation step was performed during which the Taq DNA polymerase was added, and then 25 cycles were performed (denaturation, 1 min at 94°C; annealing, 1 min at 40°C; elongation, 2 min at 72°C). The products were analyzed on a 2.5% agarose gel.
Immunostaining of viral plaques. Monolayers of HEp-2 cells in six-well plates were infected with virus, covered with Opti-MEM (Life Technologies) containing 2% fetal bovine serum and 0.9% methylcellulose, and incubated at 32°C in a CO2 incubator. Six days later, the monolayers were fixed with cold 80% methanol and stained with a mixture of three murine monoclonal antibodies against RSV F protein (23). The plaques were visualized using horseradish peroxidase-labeled goat anti-mouse immunoglobulin G (IgG; Kirkegaard & Perry Laboratories). The average plaque diameter was calculated by measurement of 30 plaques for each virus.
Kinetics of viral replication in HEp-2 cells. Duplicate wells of six-well plates were infected with virus at a multiplicity of infection (MOI) of either 5 or 0.01 PFU in a total volume of 1 ml. After 3 h of adsorption at 37°C, the cells were washed three times and incubated at 37°C. At the indicated time points, 120-µl aliquots of medium were taken and replaced with an equal volume of fresh medium. Magnesium sulfate and HEPES were added to the aliquots as indicated above, and the samples were flash-frozen. Each of the duplicate samples was titrated in duplicates, and the mean concentration of the virus at each time point was determined.
Northern blot hybridization. Total intracellular RNA was isolated from virus-infected HEp-2 cells using Trizol reagent as described above, electrophoresed in denaturing agarose gel containing formaldehyde (13), transferred onto nitrocellulose membranes, and hybridized with a 32P-labeled double-stranded cDNA probe or strand-specific RNA probe specific to the RSV N, M, G, F, M2, or L gene, as indicated in the legends to Fig. 5 and 6. The bands corresponding to the individual RSV mRNAs or genomic RNA were quantitated using a Molecular Dynamics PhosphorImager. For each band, the background amount of radioactivity was subtracted.
Virus replication and immunogenicity in mice. Each of 12-week-old, respiratory-pathogen-free BALB/c mice (Charles River, Wilmington, Mass.) in groups of 20 to 21 were inoculated intranasally under light methoxyflurane anesthesia with 106 PFU of rRSV/M-G/65, rRSV/M-G-140, rRSV/M-G-160, or medium alone. On days 3, 4, and 5 following inoculation, five mice per group were sacrificed (except on day 5 for rRSV/M-G-160, when six mice were sacrificed) by CO2 asphyxiation, and nasal turbinates and lungs were harvested for quantification of virus titer by plaque assay (23, 24). Serum samples were taken from the remaining mice on day 53 postinfection. Serum IgG antibodies specific to the RSV F protein were quantitated in by enzyme-linked immunosorbent assay (ELISA) using immunoaffinity-purified F protein from cells infected with RSV Long strain as the solid-phase antigen (23).
| |
RESULTS |
|---|
|
|
|---|
Construction of rRSVs with M-G IGS of increasing length. Initially, we sought to manipulate the 44-nucleotide IGS between the SH and G genes in a complete RSV strain A2 antigenomic cDNA. However, the RSV antigenome has a tendency to acquire the insertion of a discrete fragment of 1.4 kb of heterologous sequence into the noncoding region of the SH gene during propagation in Escherichia coli. Therefore, we chose instead to work with a version of the antigenomic cDNA from which the SH gene had been deleted (Materials and Methods; Fig. 1A). As described previously, recombinant RSV lacking the SH gene grows as well as or better than wt rRSV in cell culture (forming larger plaques in HEp-2 cells, as shown in Fig. 2 below) and is slightly attenuated in the upper respiratory tracts of mice and in the upper and lower respiratory tracts of chimpanzees (4, 37). Thus, while the function of the SH protein remains unknown, its gene can be deleted with little apparent effect on RSV gene expression and replication in vitro and only a slight effect in vivo. In this SH deletion virus, the SH GE signal was fused to the M gene, replacing the M GE signal, and was followed by the 44-nucleotide SH-G IGS and the G gene (Fig. 1A). Thus, although we designate this gene junction in the SH deletion virus as M-G, it actually is identical to the naturally occurring SH-G gene junction, and hence all of the subsequent manipulations involved an authentic gene junction structure.
Using the SH deletion virus as the parent, we prepared and recovered the following panel of recombinant viruses, which are designated according the length of the M-G IGS: rRSV/M-G-16, rRSV/M-G-30, rRSV/M-G-44, rRSV/M-G-58, rRSV/M-G-72, rRSV/M-G-86, rRSV/M-G-100, rRSV/M-G-120, rRSV/M-G-140, and rRSV/M-G-160. The IGS structures of the first six viruses are shown in Fig. 1B, and those of the last four are outlined in Fig. 1C. We also had available the original SH deletion virus prepared previously (4), which has a 65-nucleotide M-G IGS and for the purposes of this report was renamed rRSV/M-G-65 (Fig. 1B). In addition, we made a second version of rRSV/M-G-100 that differed only in the sequence composition of the 100-nucleotide IGS; however, the two different versions were indistinguishable in cell culture, and only the results for the one shown in Fig. 1C will be presented. As indicated in Fig. 1, the artificially long IGS were constructed from segments derived from the naturally occurring SH-G and G-F IGS and did not contain any non-RSV sequence except for the indicated KpnI and XmaI restriction sites. The viruses were indistinguishable with regard to efficiency of recovery.Increased length of M-G IGS resulted in reduced plaque size.
The plaques formed by the various recombinant viruses in HEp-2 cell
monolayers were visualized by staining with monoclonal antibodies
against the F protein (Fig. 2); plaque
size was measured in several independent experiments. Viruses that had
an M-G IGS of 16 to 86 nucleotides were indistinguishable on the basis
of plaque size (represented in Fig. 2 by rRSV/M-G-65); wt rRSV also was
included, but it contains the SH gene and hence rRSV/M-G-65 rather than
wt rRSV should be considered the parental control for the IGS mutants.
The viruses with an M-G IGS of 100 nucleotides or more had
progressively smaller plaques and also exhibited greater heterogeneity
in plaque size compared to rRSV/M-G-65 (Fig. 2). Taking one typical
experiment as an example, with the average plaque size of rRSV/M-G-65
normalized to 1.0 (standard deviation [SD] 0.13), the relative plaque
sizes were as follows: rRSV/M-G-100, 0.90 (SD 0.13); rRSV/M-G-120, 0.83 (SD 0.16); rRSV/M-G-140, 0.80 (SD 0.26); rRSV/M-G-160, 0.68 (SD 0.28);
and wt rRSV, 0.88 (SD 0.17).
|
The modified IGS are stable.
Preparations of the various
viruses were made by amplification by four or five passages in HEp-2
cells. Intracellular RNA from each final passage was isolated and
analyzed by RT-PCR using primers that flanked the M-G IGS. The length
of the PCR product representing the M-G IGS of each recombinant RSV
corresponded to the calculated value, and shorter PCR products that
might represent deletions were not detected (Fig.
3). Thus, the modified M-G IGS appeared
to be stable.
|
Effect of increasing IGS length on single-step and multistep
replication in vitro.
Analysis of in vitro replication of the
viruses with M-G IGS of 86 nucleotides or less revealed no differences
between the viruses (results not shown). We therefore focused on the
viruses with an M-G IGS of 100 nucleotides or more. To study the
kinetics of virus replication in a single-step growth cycle, HEp-2 cell monolayers were infected at an MOI of 5 PFU per cell with various recombinant viruses containing M-G IGS of increasing length.
Aliquots from the overlying medium were taken at 8-h intervals and
analyzed later in parallel by plaque assay (Fig.
4A). In general, virus growth was delayed
and somewhat reduced with increasing IGS length, although in this
particular experiment rRSV/M-G-140 grew somewhat better than
rRSV/M-G-120. The largest differences between titers of the
fastest-growing and most attenuated viruses, rRSV/M-G-65 and
rRSV/M-G-160, respectively, were 21-fold at 24 h and 12-fold at
32 h. However, by 48 h postinfection the slower-growing
viruses had largely caught up with the rRSV/M-G-65 virus, and the
difference in titer was small.
|
Sequential transcription is not affected by the increased length of
the M-G IGS.
Transcription of individual genes of wt rRSV and of
the viruses with M-G IGS of increasing length was analyzed by Northern blot hybridization. HEp-2 cells were infected at an MOI of 5 PFU per
cell and harvested 48 h later, and total intracellular RNA was
isolated and analyzed by Northern blot hybridization with double-stranded cDNA probes. We tested transcription of the genes located upstream of the modified IGS (N and M), as well as ones located
downstream (G, F, M2, and L). Typical results are shown in Fig.
5, and the results of quantitation of the
bands corresponding to G and F mRNA using phosphorimagery are presented
in Table 1. Surprisingly, there was
little or no consistent difference between the different viruses in the
level of expression of the various mRNAs. In particular, the efficiency
of transcription of genes downstream of the M-G IGS, and the frequency
of readthrough transcription across the M-G IGS, appeared to be
unaffected by its increasing length. The accumulation of genomic
and antigenomic RNAs, which migrate as a single band, also did not
appear to vary in a consistent manner among the different
viruses.
|
|
|
|
Replication in vivo and immunogenicity of viruses containing M-G IGS of increasing length. It was of interest to determine whether the decreased plaque size and reduction in single-cycle growth in vitro was reflected by decreased replication of virus in vivo. We compared the abilities of rRSV/M-G-65, rRSV/M-G-140, and rRSV/M-G-160 to replicate in the respiratory tracts of mice. Tissues from BALB/c mice inoculated intranasally were harvested on days 3, 4, and 5 postinfection, and virus titers in the nasal turbinates and lungs were measured (Table 2). In the nasal turbinates, day 3 titers of rRSV/M-G-140 and rRSV/M-G-160 were 2.4-fold (P < 0.02) and 5.0-fold (P < 0.001), respectively, lower than that of rRSV/M-G-65. On the same day, titers of rRSV/M-G-140 and rRSV/M-G160 in the lungs were 25.3-fold (P < 0.05) and 17.6-fold (P < 0.02) respectively, lower than that of rRSV/M-G-65. On days 4 and 5, no significant difference was found among the three viruses.
The immunogenicity of the viruses was compared by taking serum samples on days 53 (Table 2) and 66 (not shown) postinfection and determining the titers of IgG specific to the RSV F protein by ELISA. The viruses were equally and highly immunogenic.| |
DISCUSSION |
|---|
|
|
|---|
Mononegaviruses exhibit two alternative patterns with respect to IGS. Viruses such as VSV (a vesiculovirus), Sendai virus (a respirovirus), and measles virus (a morbillivirus) contain highly conserved di- or trinucleotide IGS. Studies with minireplicons indicate that these are important in termination and reinitiation during sequential transcription (see the introduction). In contrast, other mononegaviruses such as RSV, SV5 (rubulavirus), and the filoviruses have IGS that vary in length and do not appear to contain a conserved sequence motif. In an RSV minigenome, the variable IGS did not appear to play an important role in transcription, although in an SV5 minigenome at least one IGSinfluenced transcription (25). Previous studies with these two types of IGS, conserved and variable, focused on comparing the naturally occurring IGS or involved nucleotide substitutions or small length changes (1, 14, 15, 20, 31, 32). Particularly in the case of RSV, we felt that the possibility that the length of the IGS might be an important regulatory feature remained to be further explored, and that it would be useful to do so in the context of an infectious virus rather than a minireplicon. This was done in the present study by creating a panel of recombinant RSVs with M-G IGS of increasing length, such that the longest version was nearly three times the length of the longest naturally occurring RSV IGS. These experiments were performed using an SH-minus viral backbone in order to facilitate assembly of the full-length cDNAs. Effects on gene expression and growth in vitro and in vivo were examined.
Increasing the M-G IGS from 16 to 86 nucleotides had no discernible effect on the growth of recombinant RSV in cell culture. An IGS of 100 nucleotides or longer resulted in a modest decrease in viral growth as assayed by plaque size or single-step growth yield, but attenuation was not observed in multistep growth. The basis for this modest attenuation remains unclear. In other work, we have found that, other factors being equal, the replication of RSV in cell culture is very sensitive to the length of the genome, a characteristic that is in sharp contrast with other mononegaviruses (26, 29). For example, deletion of the SH gene (4) or of a noncoding gene segment (A. Bukreyev and P. Collins, unpublished data) resulted in increased plaque size and in some cases an increased yield of virus in liquid overlay. Conversely, the addition of a foreign gene whose encoded protein would not be expected to affect RSV growth, such as chloramphenicol acetyltransferase or luciferase, resulted in decreased plaque size and decreased virus yield, and the magnitude of these effects was much greater with longer genes (3; Bukreyev and Collins, unpublished).
In the present study, the level of attenuation of in vitro growth increased as the length of the IGS increased. For example, taking the plaque size of rRSV/M-G-65 (genome of 14,825 nucleotides) as 1.0, rRSV/M-G-120 (14,880 nucleotides) had a plaque size of 0.83 and rRSV/M-G-160 (14,920 nucleotides) had a plaque size of 0.68. Thus, plaque size seemed to be remarkably sensitive to small changes in length. It is not clear whether this was simply a function of increasing genome length, or whether there was some augmented effect because the length change was in an IGS.
We included wt rRSV in the comparison for descriptive purposes. However, it should not be used as a comparison to evaluate the effect of length on plaque size because it expresses an additional gene, the SH gene, whose effect on growth remains unclear. The average plaque size of wt rRSV was intermediate (0.88, normalized to a value of 1.0 for rRSV/M-G-65) among the IGS mutants even though its genome was substantially longer (15,223 nucleotides). We speculate that the inhibitory effect of the greater length might have been compensated for by the expression of the SH protein, which certainly enhances growth in vivo (4, 37) and likely does the same in vitro.
We had anticipated that the diminution in plaque size observed with viruses containing an M-G IGS of 100 to 160 nucleotides would be associated with a change in the efficiency of sequential transcription. In particular, we had anticipated that increased IGS length would be associated with increased polymerase falloff and consequential decreased transcription of downstream genes. Surprisingly, Northern blot analysis did not detect any difference in the amount or kinetics of accumulation for several mRNAs and readthrough mRNAs from genes upstream and downstream of the M-G IGS. We cannot rule out the possibility that there was an effect on transcription that was too small to be detected by Northern blots but was sufficient to alter growth, but such an effect would have to be small indeed to have been missed here.
A simple model of RSV transcription is as follows. The transcriptase
switches into a transcribing mode upon encountering a GS signal. The
transcribing complex is then converted to a stable elongation complex
by association with the P protein and likely is further stabilized by
the M2-1 antitermination protein (7, 9). Upon encountering a
GE signal, the transcriptase then switches into a
stuttering-termination mode, which adds a poly(A) tail and releases the
mRNA. Thereafter, the transcriptase can either dissociate or remain
template bound. In the latter case, it scans for the next GS signal. At
least for the M2-L gene junction, the transcriptase apparently can scan
in either direction (10). The present study indicates that
the transcriptase can scan for at least 160 nucleotides in the
downstream direction with no discernible increase in fall off or
reduction in the efficiency of reinitiation. Given that the longest
artificial IGS was 160 nucleotides
nearly 40% the length of the
smallest RSV gene
it is difficult to imagine that this scanning
can occur while the transcriptase remains at the GE signal. The same
point of view is supported by noting that the incremental increases in
length for the IGS of 100, 120, 140, and 160 nucleotides are much
smaller than would correspond to turns in the nucleocapsid helix. Thus,
higher-order structure likely does not provide access from the upstream
GE signal to the downstream GS signal. We therefore imagine that the
transcriptase slides along the IGS without synthesis; prokaryotic and
eukaryotic DNA-dependent RNA polymerases also are thought to slide
along the template prior to initiation at a transcription start site (12). If the RSV transcriptase indeed slides on the IGS,
this apparently involves a stable interaction, since increasing IGS length was not associated with a detectable increase in falloff within
the site range examined here. We are presently extending this study
using longer IGS in a minigenome system, which will allow greater
experimental control and in particular will allow us to examine whether
the M2-1 transcription antitermination factor is involved in sliding
along the IGS.
Changes in the length of an IGS would not be expected to have any direct effect on RNA replication. However, the Northern blot analysis indicated that the amount of intracellular genomic RNA was slightly increased for the longer genomes (rRSV/M-G-140 and rRSV/M-G-160) at 24 and 32 h postinfection (Fig. 6A and C). Further work will be necessary to determine whether this apparent increase is a consistent effect of increased IGS length or, more likely, of increased genome length in general. These time points corresponded with diminished release of infectious particles for these viruses (Fig. 4A). One possibility is that the two effects are linked, and that greater genome length decreases the efficiency of packaging, thereby increasing the intracellular accumulation of viral genome.
The replication of rRSV/M-G-140 and rRSV/M-G-160 in mice was modestly attenuated compared to rRSV/M-G-65 on day 3 in both the upper and lower respiratory tracts. However, there was not a significant difference on days 4 and 5 postinfection. These results appear to parallel the kinetics of virus replication observed in vitro, where a reduction of virus replication associated with increased IGS length was observed during single-cycle growth but not during multicycle growth. We previously showed that recombinant RSV with the SH gene deleted (rRSV/M-G-65) displayed a 10-fold reduction in replication in the nasal turbinates of BALB/c mice, whereas replication in the lungs was unaffected (4). Therefore, the attenuation in the upper respiratory tract observed here in response to an increase in IGS length presumably was additive to that due to the deletion of the SH gene. Attenuation due to increasing IGS length was not accompanied by a decrease in immunogenicity. This was not unexpected, since reduced immunogenicity typically is observed only with strongly attenuated viruses. The ability to introduce a small increase in attenuation is of potential value for designing a live-attenuated RSV vaccine. In this context, it will be important to compare the effects of artificially long IGS in complete wt rRSV containing the SH gene versus highly attenuated vaccine candidate viruses.
One of the themes that has emerged from studies of recombinant mononegaviruses is the surprising flexibility and stability of the genome in accommodating mutations. These can include the deletion of genes (2, 4, 33), the insertion of foreign genes (3, 22, 28), rearrangement of gene order (36), and substitution of cis-acting signals (11). In the present study, this list is expanded by the observation that an unnaturally long IGS could be introduced into the RSV genome with no apparent effect on sequential transcription and little effect on virus growth.
| |
ACKNOWLEDGMENTS |
|---|
We thank Myron Hill, Kim Tran, Ena Camargo, and Chris J. Cho for technical assistance.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Building 7, Room 100, NIAID, NIH, 7 Center Dr. MSC 0720, Bethesda, MD 20892-0720. Phone: (301) 594-1590. Fax: (301) 496-8312. E-mail: pcollins{at}niaid.nih.gov.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Barr, J. N., S. P. Whelan, and G. W. Wertz. 1997. Role of the intergenic dinucleotide in vesicular stomatitis virus RNA transcription. J. Virol. 71:1794-1801[Abstract]. |
| 2. |
Bermingham, A., and P. L. Collins.
1999.
The M2-2 protein of human respiratory syncytial virus is a regulatory factor involved in the balance between RNA replication and transcription.
Proc. Natl. Acad. Sci. USA
96:11259-11264 |
| 3. |
Bukreyev, A.,
E. Camargo, and P. L. Collins.
1996.
Recovery of infectious respiratory syncytial virus expressing an additional, foreign gene.
J. Virol.
70:6634-6641 |
| 4. | Bukreyev, A., S. S. Whitehead, B. R. Murphy, and P. L. Collins. 1997. Recombinant respiratory syncytial virus from which the entire SH gene has been deleted grows efficiently in cell culture and exhibits site-specific attenuation in the respiratory tract of the mouse. J. Virol. 71:8973-8982[Abstract]. |
| 5. |
Collins, P. L.,
L. E. Dickens,
A. Buckler-White,
R. A. Olmsted,
M. K. Spriggs,
E. Camargo, and K. V. Coelingh.
1986.
Nucleotide sequences for the gene junctions of human respiratory syncytial virus reveal distinctive features of intergenic structure and gene order.
Proc. Natl. Acad. Sci. USA
83:4594-4598 |
| 6. |
Collins, P. L.,
M. G. Hill,
E. Camargo,
H. Grosfeld,
R. M. Chanock, and B. R. Murphy.
1995.
Production of infectious human respiratory syncytial virus from cloned cDNA confirms an essential role for the transcription elongation factor from the 5' proximal open reading frame of the M2 mRNA in gene expression and provides a capability for vaccine development.
Proc. Natl. Acad. Sci. USA
92:11563-11567 |
| 7. |
Collins, P. L.,
M. G. Hill,
J. Cristina, and H. Grosfeld.
1996.
Transcription elongation factor of respiratory syncytial virus, a nonsegmented negative-strand RNA virus.
Proc. Natl. Acad. Sci. USA
93:81-85 |
| 8. | Collins, P. L., K. McIntosh, and R. M. Chanock. 1996. Respiratory syncytial virus, p. 1313-1352. In B. N. Fields, D. M. Knipe, P. M. Howley, R. M. Chanock, J. L. Melnick, T. P. Monath, B. Roizman, and S. E. Straus (ed.), Fields virology, 3rd ed., vol. 2. Lippincott-Raven, Philadelphia, Pa. |
| 9. |
Dupuy, L. C.,
S. Dobson,
V. Bitko, and S. Barik.
1999.
Casein kinase 2-mediated phosphorylation of respiratory syncytial virus phosphoprotein P is essential for the transcription elongation activity of the viral polymerase; phosphorylation by casein kinase 1 occurs mainly at Ser215 and is without effect.
J. Virol.
73:8384-8392 |
| 10. |
Fearns, R., and P. L. Collins.
1999.
Model for polymerase access to the overlapped L gene of respiratory syncytial virus.
J. Virol.
73:388-397 |
| 11. | Garcin, D., T. Pelet, P. Calain, L. Roux, J. Curran, and D. Kolakofsky. 1995. A highly recombinogenic system for the recovery of infectious Sendai paramyxovirus from cDNA: generation of a novel copy-back nondefective interfering virus. EMBO J. 14:6087-6094[Medline]. |
| 12. | Gelles, J., and R. Landick. 1998. RNA polymerase as a molecular motor. Cell 93:13-16[CrossRef][Medline]. |
| 13. | Grosfeld, H., M. G. Hill, and P. L. Collins. 1995. RNA replication by respiratory syncytial virus (RSV) is directed by the N, P, and L proteins; transcription also occurs under these conditions but requires RSV superinfection for efficient synthesis of full-length mRNA. J. Virol. 69:5677-5686[Abstract]. |
| 14. |
Hardy, R. W.,
S. B. Harmon, and G. W. Wertz.
1999.
Diverse gene junctions of respiratory syncytial virus modulate the efficiency of transcription termination and respond differently to M2-mediated antitermination.
J. Virol.
73:170-176 |
| 15. |
He, B., and R. Lamb.
1999.
Effect of inserting paramyxovirus simian virus 5 gene junctions at the HN/L gene junction: analysis of accumulation of mRNAs transcribed from rescued viable viruses.
J. Virol.
73:6228-6234 |
| 16. |
Jin, H.,
X. Cheng,
H. Zhou,
S. Li, and A. Seddiqui.
2000.
Respiratory syncytial virus that lacks open reading frame 2 of the M2 gene (M2-2) has altered growth characteristics and is attenuated in rodents.
J. Virol.
74:74-82 |
| 17. |
Johnson, P. R., and P. L. Collins.
1988.
The A and B subgroups of human respiratory syncytial virus: comparison of intergenic and gene-overlap sequences.
J. Gen. Virol.
69:2901-2906 |
| 18. |
Kawano, M.,
K. Okamoto,
H. Bando,
K. Kondo,
M. Tsurudome,
H. Komada,
M. Nishio, and Y. Ito.
1991.
Characterizations of the human parainfluenza type 2 virus gene encoding the L protein and the intergenic sequences.
Nucleic Acids Res.
19:2739-2746 |
| 19. |
Kolakofsky, D.,
T. Pelet,
D. Garcin,
S. Hausmann,
J. Curran, and L. Roux.
1998.
Paramyxovirus RNA synthesis and the requirement for hexamer genome length: the rule of six revisited.
J. Virol.
72:891-899 |
| 20. | Kuo, L., R. Fearns, and P. L. Collins. 1996. The structurally diverse intergenic regions of respiratory syncytial virus do not modulate sequential transcription by a dicistronic minigenome. J. Virol. 70:6143-6150[Abstract]. |
| 21. | Lamb, R. A., and D. Kolakofsky. 1996. Paramyxoviridae: the viruses and their replication, p. 1177-1204. In B. N. Fields, D. M. Knipe, P. M. Howley, R. M. Chanock, J. L. Melnick, T. P. Monath, B. Roizman, and S. E. Straus (ed.), Fields virology, 3rd ed., vol. 1. Lippincott-Raven Publishers, Philadelphia, Pa. |
| 22. |
Mebatsion, T.,
M. J. Schnell,
J. H. Cox,
S. Finke, and K. K. Conzelmann.
1996.
Highly stable expression of a foreign gene from rabies virus vectors.
Proc. Natl. Acad. Sci. USA
93:7310-7314 |
| 23. | Murphy, B. R., A. V. Sotnikov, L. A. Lawrence, S. M. Banks, and G. A. Prince. 1990. Enhanced pulmonary histopathology is observed in cotton rats immunized with formalin-inactivated respiratory syncytial virus (RSV) or purified F glycoprotein and challenged with RSV 3-6 months after immunization. Vaccine 8:497-502[CrossRef][Medline]. |
| 24. | Prince, G. A., A. B. Jenson, R. L. Horswood, E. Camargo, and R. M. Chanock. 1978. The pathogenesis of respiratory syncytial virus infection in cotton rats. Am. J. Pathol. 93:771-791[Abstract]. |
| 25. |
Rassa, J. C., and G. D. Parks.
1999.
Highly diverse intergenic regions of the paramyxovirus simian virus 5 cooperate with the gene end U tract in viral transcription termination and can influence reinitiation at a downstream gene.
J. Virol.
73:3904-3912 |
| 26. | Sakai, Y., K. Kiyotani, M. Fukumura, M. Asakawa, A. Kato, T. Shioda, T. Yoshida, A. Tanaka, M. Hasegawa, and Y. Nagai. 1999. Accommodation of foreign genes into the Sendai virus genome: sizes of inserted genes and viral replication. FEBS Lett. 456:221-226[CrossRef][Medline]. |
| 27. | Sanchez, A., M. Kiley, B. Holloway, and D. Auperin. 1993. Sequence analysis of the Ebola virus genome: organization, genetic elements, and comparison with the genome of Marburg virus. Virus Res. 29:215-240[CrossRef][Medline]. |
| 28. | Schnell, M. J., L. Buonocore, M. A. Whitt, and J. K. Rose. 1996. The minimal conserved transcription stop-start signal promotes stable expression of a foreign gene in vesicular stomatitis virus. J. Virol. 70:2318-2323[Abstract]. |
| 29. | Skiadopoulos, M. H., S. R. Surman, A. P. Durbin, P. L. Collins, and M. B. R.. 2000. Long nucleotide insertions between the HN and the L protein coding regions of human parainfluenza virus type 3 yield viruses with temperature sensitive and attenuation phenotypes. Virology 272:225-234[CrossRef][Medline]. |
| 30. |
Stillman, E., and M. Whitt.
1999.
Transcript initiation and 5'-end modifications are separable events during vesicular stomatitis virus transcription.
J. Virol.
73:7199-7209 |
| 31. | Stillman, E. A., and M. A. Whitt. 1998. The length and sequence composition of vesicular stomatitis virus intergenic regions affect mRNA levels and the site of transcript initiation. J. Virol. 72:55565-55572. |
| 32. | Stillman, E. A., and M. A. Whitt. 1997. Mutational analyses of the intergenic dinucleotide and the transcriptional start sequence of vesicular stomatitis virus (VSV) define sequences required for efficient termination and initiation of VSV transcripts. J. Virol. 71:2127-2137[Abstract]. |
| 33. |
Teng, M. N., and P. L. Collins.
1999.
Altered growth characteristics of recombinant respiratory syncytial viruses which do not produce NS2 protein.
J. Virol.
73:466-473 |
| 34. |
Tordo, N. P. O.,
A. Ermine,
G. Keith, and F. Rougeon.
1986.
Walking along the rabies genome: is the large G-L intergenic region a remnant gene?
Proc. Natl. Acad. Sci. USA
83:3914-3918 |
| 35. | Wagner, R. R., and J. K. Rose. 1996. Rhabdoviridae: the viruses and their replication, p. 1121-1135. In B. N. Fields, D. M. Knipe, P. M. Howley, R. M. Chanock, J. L. Melnick, T. P. Monath, B. Roizman, and S. E. Straus (ed.), Fields virology, 3rd ed., vol. 1. Lippincott-Raven Publishers, Philadelphia, Pa. |
| 36. |
Wertz, G.,
V. Perepelitsa, and L. Ball.
1998.
Gene rearrangement attenuates expression and lethality of a nonsegmented negative strand RNA virus.
Proc. Natl. Acad. Sci. USA
95:3501-3506 |
| 37. |
Whitehead, S. S.,
A. Bukreyev,
M. N. Teng,
C. Y. Firestone,
M. St. Claire,
W. R. Elkins,
P. L. Collins, and B. R. Murphy.
1999.
Recombinant respiratory syncytial virus bearing a deletion of either the NS2 or SH gene is attenuated in chimpanzees.
J. Virol.
73:3438-3442 |
| 38. |
Whitehead, S. S.,
C. Y. Firestone,
R. A. Karron,
J. E. Crowe, Jr.,
W. R. Elkins,
P. L. Collins, and B. R. Murphy.
1999.
Addition of a missense mutation present in the L gene of respiratory syncytial virus (RSV) cpts530/1030 to RSV vaccine candidate cpts248/404 increases its attenuation and temperature sensitivity.
J. Virol.
73:871-877 |
| 39. | Yu, Q., R. W. Hardy, and G. W. Wertz. 1995. Functional cDNA clones of the human respiratory syncytial (RS) virus N, P, and L proteins support replication of RS virus genomic RNA analogs and define minimal trans-acting requirements for RNA replication. J. Virol. 69:2412-2419[Abstract]. |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»